Established in 2023, Osteo Biotech (BEIJING) Co., Ltd. is a high-tech enterprise jointly founded by Peking University School of Stomatology, Dianyun Biotechnology, Maihai Materials Genome, social capital, and elites from the dental industry. We are committed to promoting import substitution of high-value dental and orthopedic consumables and achieving leapfrog development in key technologies based on its independently developed next-generation regenerative medicine materials and 3D printing equipment platform.
Our first product, "Bioglass Artificial Bone for Dental Use," originated from a 2021 National Key Clinical Specialty Technology Transformation Project. Led by Peking University School of Stomatology, this project brought together industry experts from Northwestern Polytechnical University, Dianyun Biotechnology, and Maihai Materials Genome International Research Institute, successfully completing in 2023 and obtaining three national invention patents. Currently, the product has completed technology transfer, and OSTEO (BEIJING) BIOTECH CO., LTD. is fully responsible for its industrialization.
We have always adhered to the business philosophy of "innovation as the key and quality as the foundation" and the corporate spirit of "focus, responsibility and pragmatism". It focuses on the field of medical devices and is committed to building a high-end medical device company that integrates production, learning, research and development and sales.
